The Tempsens Instruments IPO drew strong interest from investors on its first day. The issue received total bids of about 5.93–5.94 times the shares on offer. The response was not equal across all investor groups. Non-institutional investors showed very strong demand, while retail investors also placed bids at a high level. Qualified institutional buyers, or QIBs, had a much lower response at the end of Day 1.
This strong demand may look positive at first view. However, IPO subscription data alone does not establish whether a company is cheap, fairly priced, or suitable for a particular investor. Subscription levels can reflect short-term market interest, expectations about listing gains, and demand from different investor categories.
Tempsens Instruments operates in a specialised industrial field. Its business focuses on temperature sensors and related thermal engineering products. The company serves sectors such as metals, petrochemicals and other industrial applications. This gives the company exposure to industrial demand and may offer scope for future growth. At the same time, such sector exposure also creates business risks that investors need to assess.
The IPO has a total size of ₹650 crore. The price band stands at ₹285–₹300 per share. Of the total issue, ₹95 crore represents fresh capital. The balance ₹555 crore comes through an offer for sale, or OFS. This structure matters because most of the money from the issue does not go directly into the company.
This review uses a cautious approach. It does not suggest that an investor should buy or avoid the issue. Instead, it explains the available data in simple terms so that an investor can assess the opportunity against personal risk, investment horizon and valuation expectations.
What Happened on Day 1
The overall IPO subscription stood at about 5.93–5.94 times on Day 1. This means that investors placed bids for almost six times the number of shares available under the relevant issue structure.
The non-institutional investor, or NII, category showed particularly strong demand. It reached about 12.5 times subscription. The retail category also showed a strong response at about 6.4 times. In contrast, QIB demand was still low at the end of Day 1.
This mix is important. A strong NII and retail response can show high interest from market participants, but the QIB response can also matter because institutional demand often provides a different view of the issue. A low QIB response on Day 1 does not by itself mean that institutions reject the company. QIB bids can rise later in the IPO period.
By Day 2, the demand had moved higher. Reports placed the subscription above 7 times by around 10:15 AM, with later updates showing a stronger level. This change suggests that investor interest remained firm after the first day.
However, subscription figures should not be treated as a forecast of the share price after listing. A highly subscribed IPO can still list below expectations, and a less popular issue can perform better later if its business results improve.
IPO Structure and Use of Funds
The total issue size is ₹650 crore. The price band is ₹285–₹300 per share.
The fresh issue is worth ₹95 crore. This portion creates new shares and gives the company access to fresh funds. The company can use such capital for its stated corporate purposes, subject to the terms of the IPO documents.
The OFS component is much larger at ₹555 crore. Under an OFS, existing shareholders sell part of their holdings. The money from those shares generally goes to the selling shareholders rather than to the company.
| IPO detail | Data |
|---|---|
| Total issue size | ₹650 crore |
| Price band | ₹285–₹300 |
| Fresh issue | ₹95 crore |
| Offer for sale | ₹555 crore |
| Day 1 total subscription | About 5.93–5.94× |
| NII subscription | About 12.5× |
| Retail subscription | About 6.4× |
| Day 1 GMP reported | About ₹220 |
| Reported GMP premium | About 73% |
The high OFS share does not automatically make an IPO unattractive. Existing investors can sell shares for several legitimate reasons. However, a prospective investor should understand that only ₹95 crore of the ₹650 crore issue represents fresh capital for the company.
Business Profile
Tempsens Instruments operates in a specialised industrial market. Its products relate to temperature measurement and thermal engineering. These products can form an important part of industrial processes where accurate temperature control and measurement are required.
The company has exposure to areas such as metals and petrochemicals. Such industries require industrial instruments and systems for various processes. Demand from these sectors can therefore support the company when capital expenditure and industrial activity remain healthy.
A specialised business can have an advantage if it develops technical expertise, customer relationships and product quality. Customers may not replace technical suppliers without a reason, especially where product reliability has a direct effect on industrial operations.
At the same time, industrial businesses can face periods of weak demand. Orders may depend on new projects, factory expansion, capital expenditure and broader economic conditions. A slowdown in key customer sectors can affect revenue and margins.
The business case should therefore rest on more than the IPO subscription number. Investors should assess whether the company can maintain revenue growth, protect margins and expand its customer base over several years.
Financial Performance
The available FY26 figures show revenue of about ₹444.9 crore. This represents growth of about 17.5%. Profit for the year was about ₹67.3 crore.
These numbers indicate a profitable business with a meaningful revenue base. Revenue growth of 17.5% is also useful context because it shows that the company had a period of healthy expansion before the IPO.
| Financial measure | FY26 data |
| Revenue | About ₹444.9 crore |
| Revenue growth | About 17.5% |
| Profit | About ₹67.3 crore |
Past financial results, however, do not guarantee future results. Future revenue can depend on industrial demand, customer orders, pricing, raw material costs, foreign markets and the company’s ability to execute its business plans.
An investor should also review cash flow, debt, working capital and return ratios before making a decision. Profit on the income statement and cash available to the company are not always the same. A business can report profit while a large amount of cash remains tied up in receivables or inventory.
The Role of GMP
The reported grey market premium, or GMP, was around ₹220 on Day 1. Against the upper price band of ₹300, this suggested a premium of about 73%.
GMP is an unofficial market indicator. It is not part of the formal IPO process and does not guarantee a listing price. It can change before listing and may differ from the actual market price after listing.
A high GMP can show strong short-term expectations. It can also attract more attention from investors who seek a possible listing gain. But this creates a risk if expectations become too high.
For example, if a stock lists at a premium but then faces profit booking, the market price can fall quickly. An investor who buys only because of a high GMP may therefore face a different result from the one expected before listing.
GMP can be used as one market signal, but it should not replace analysis of the company’s earnings, valuation, balance sheet, industry position and risks.
Valuation Needs Care
The main issue for a long-term investor is not simply whether Tempsens has a good business. The question is whether the IPO price offers enough value for the risks involved.
A strong company can still be a poor investment if the entry price is too high. The opposite can also be true. A company with ordinary near-term results can offer an attractive investment if the valuation leaves enough room for future growth.
The reported GMP of about ₹220 creates an expectation of a large listing premium. That may make the issue look attractive for a short-term trade. Yet a long-term investor should focus on what the company can earn over several years.
The IPO price of ₹285–₹300 should therefore be assessed against earnings per share, peer valuations, expected growth, margins and cash flow. Without such comparison, a conclusion based only on subscription and GMP would be incomplete.
Key Business Risks
Tempsens has exposure to industrial sectors such as metals and petrochemicals. A fall in activity in these sectors can affect order volumes. Large industrial projects can also have long sales cycles, which can make quarterly results uneven.
Raw material prices may also affect margins. If input costs rise faster than the company can adjust product prices, profitability can come under pressure.
Working capital is another point that deserves attention. Industrial businesses can need substantial funds for inventory and customer receivables. If customers take longer to pay, cash can remain tied up even when reported revenue and profit rise.
The company also operates in a specialised market. Technical expertise can support its position, but competition remains a factor. Other domestic and international suppliers may compete on product quality, price, technology and customer service.
There is also an IPO structure risk from the large OFS component. Since ₹555 crore of the ₹650 crore issue is an OFS, most of the proceeds do not add fresh funds to the company’s balance sheet.
These factors do not mean that the company has a weak business. They simply show why an investor should consider both the opportunity and the downside.
Day 2 Demand and What It Means
The rise in subscription on Day 2 confirms that investor interest remained strong. Reports placed total subscription above 7 times by around 10:15 AM, with later reports showing further growth.
This is a positive sign from a demand perspective. Still, the data should be read with care.
Subscription figures can rise rapidly because of demand from particular investor categories. They do not measure the future earnings of the company. They also do not tell an investor whether the post-listing price will remain above the IPO price.
The quality of demand is therefore more important than the headline number alone. Investors should look at the final category-wise subscription figures along with the issue valuation and company fundamentals.
Listing Gain Versus Long-Term Investment
There are two different ways an investor may view the IPO.
A short-term investor may focus on subscription, GMP and market sentiment. From that perspective, the strong Day 1 demand and reported GMP of around ₹220 create a positive short-term setup. However, this strategy carries market risk because GMP is unofficial and listing prices can change quickly.
A long-term investor should use a different framework. The focus should be on revenue growth, profit growth, margins, cash flow, debt, industry demand, competitive strength and valuation.
This distinction is important. An IPO can offer a strong listing gain and still become an average long-term investment. In the same way, a stock can have a weak listing and later perform well if the company delivers strong business results.
Balanced Assessment
The Tempsens Instruments IPO has several points that may attract investors. The company operates in a specialised industrial segment, has reported revenue growth, remains profitable and has received strong subscription demand.
At the same time, the valuation needs careful review. The high reported GMP may create an optimistic market view that may not last. The large OFS component also means that only a limited part of the issue proceeds represents fresh capital for the company.
Industrial sector exposure, working-capital needs and dependence on customer industries are further factors that deserve attention.
The available information therefore supports a balanced view rather than an aggressive conclusion. The IPO has visible strengths, but those strengths should be weighed against the price paid for the shares.
Conclusion
Tempsens Instruments has attracted strong investor interest during its IPO. The Day 1 subscription of about 5.93–5.94 times, NII demand of about 12.5 times and retail demand of about 6.4 times show that the issue received a strong early response. Demand rose further on Day 2.
The company’s FY26 revenue of about ₹444.9 crore and profit of about ₹67.3 crore provide a useful financial base. Revenue growth of about 17.5% also adds to the positive picture.
Yet the investment case should not rely on subscription figures or GMP alone. The reported GMP of around ₹220, or about 73% above the upper price band, is an unofficial indicator and can change. It should not be treated as a guaranteed listing return.
The ₹650 crore issue also deserves close attention because ₹555 crore comes through an OFS, while only ₹95 crore represents a fresh issue.
For a potential investor, the central question is simple: Does the IPO price provide enough value after accounting for the company’s growth prospects and risks?
That answer can differ from one investor to another. A person who seeks a short-term listing opportunity may view the strong demand as useful market evidence, while a long-term investor may require a more detailed valuation and financial review before taking a position.
This article is for general information and analysis only. It is not investment advice, a recommendation to subscribe, or a guarantee of any listing or future market price. Investors should review the official IPO documents, financial statements, risk factors and applicable disclosures before making an investment decision.
ALSO READ: Tempsens Instruments IPO: Demand, Valuation and Key Risks
